PATENT CLAIM ANALYSIS

Application Number: 16217527
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "472000"]

Abstract:
Uses of acyl-homoserine lactone compounds are described. In particular, uses of acyl-homoserine lactone compounds as anti-thrombotic agents, to inhibit platelets from becoming hypersensitive, and/or to prevent thrombosis, are described.

Claim (Index 13):
The method of  claim 12 , wherein the chemotherapeutic agent, or rheumatoid arthritis treatment is selected from the group consisting of: platinum coordination compounds; taxane compounds; topoisomerase I inhibitors; topoisomerase II inhibitors; anti-tumor vinca alkaloids; anti-tumor nucleoside derivatives; alkylating agents; anti-tumor anthracycline derivatives; HER2 antibodies; estrogen receptor antagonists or selective estrogen receptor modulators; aromatase inhibitors; differentiating agents; DNA methyl transferase inhibitors; kinase inhibitors; farnesyltransferase inhibitors; HDAC inhibitors; other inhibitors of the ubiquitin-proteasome pathway; PI3 kinase inhibitors; corticosteroids; anti-inflammatory agents; immunosuppressants; anti-malarial drugs; statins; diuretics; disease-modifying antirheumatic drugs (DMARDs); anti-inflammatory agents; corticosteroids; and proteins.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 98.0
- Lexical Diversity: 1.45833
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15764684', '14778327', '12019593', '10861224', '12676287']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8046664175780986
- 35 USC 102 Novelty (BERT): 0.5973281859731868
- Combined Prediction Score: 0.7839325944176075
- Mean Citation Score: 327.74213999999995
- Max Citation Score: 638.7832
- Similarity Product: 421.8610131083012

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test